Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Discontinuation of growth… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children.

Artikel i vetenskaplig tidskrift
Författare Gudmundur Johannsson
Kerstin Albertsson-Wikland
B A Bengtsson
Publicerad i The Journal of clinical endocrinology and metabolism
Volym 84
Nummer/häfte 12
Sidor 4516-24
ISSN 0021-972X
Publiceringsår 1999
Publicerad vid Institutionen för invärtesmedicin
Sidor 4516-24
Språk en
Länkar dx.doi.org/10.1210/jcem.84.12.6176
www.ncbi.nlm.nih.gov/entrez/query.f...
Ämnesord Adolescent, Adult, Apolipoproteins B, blood, Blood Glucose, metabolism, Blood Pressure, Body Composition, Cardiovascular Diseases, blood, Cholesterol, blood, Cholesterol, HDL, blood, Cholesterol, LDL, blood, Female, Human Growth Hormone, deficiency, therapeutic use, Humans, Insulin-Like Growth Factor Binding Protein 3, blood, Insulin-Like Growth Factor I, metabolism, Lipids, blood, Male, Prospective Studies, Risk Factors
Ämneskategorier Endokrinologi, Pediatrik

Sammanfattning

The need for continuing GH replacement in patients with childhood-onset GH deficiency continuing into adulthood has been recognized. The metabolic consequences of discontinuing GH in adolescent patients with childhood-onset GH deficiency and short stature were examined over a period of 2 yr. Forty adolescents (aged 16-21 yr) receiving GH treatment for more than 3 yr and 16 closely matched healthy controls were studied. After a baseline visit, GH treatment was discontinued. The patients were then examined with the same protocol once a year for 2 yr. Twenty-one patients had severe GH deficiency (GHD) into adulthood, whereas 19 patients were regarded as having sufficient endogenous GH secretion (GHS). After 2 yr without GH treatment, the serum insulin-like growth factor I level was lower in GHD than in both GHS and control subjects. Both before and 2 yr after GH treatment was discontinued, serum concentrations of total cholesterol (C), low density lipoprotein C, and apolipoprotein B were higher in the GHD than in both GHS and control subjects. Serum concentrations of high density lipoprotein C decreased in the GHD group and increased in the other 2 study groups. The amount of total body and abdominal fat mass throughout the study and the increment in these masses were more marked in the GHD than in the GHS and control subjects when GH treatment was discontinued. The discontinuation of GH therapy in adolescents with severe GHD continuing into adulthood results over a period of 2 yr in the accumulation of important cardiovascular risk factors that are associated with GHD in adults.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?